Related Experiment Videos
IL-1 beta and IL-3-like activity in preterm infants
1Haematology Research Laboratory, Hasharon Hospital, Golda Medical Centre, Tel Aviv University Medical School, Petah-Tiqva, Israel.
Insights
Preterm neonates show reduced capacity for releasing IL-1 beta and IL-3-like activity (IL-3-LA). This impaired immune response may contribute to their increased susceptibility to infections.
Area of Science:
- Immunology
- Neonatal Health
- Hematopoiesis
Background:
- Preterm neonates exhibit unique immunological profiles compared to full-term infants and adults.
- Interleukin-1 beta (IL-1 beta) and IL-3-like activity (IL-3-LA) are crucial cytokines involved in immune responses and hematopoiesis.
Purpose of the Study:
- To investigate the capacity of peripheral blood mononuclear cells (PBMC) from preterm neonates to release IL-1 beta and IL-3-LA.
- To compare this capacity with that of maternal and adult controls.
- To assess the influence of preterm serum on PBMC cytokine production.
Main Methods:
- Isolation and culture of peripheral blood mononuclear cells (PBMC) from preterm neonates, their mothers, and adult controls.
- Measurement of IL-1 beta and IL-3-like activity (IL-3-LA) released by PBMC.
- Incubation of adult control PBMC with preterm, maternal, and adult sera to evaluate serum effects.
Main Results:
- PBMC from preterm neonates demonstrated significantly lower release of IL-1 beta and IL-3-LA compared to maternal and adult controls.
- Preterm serum exhibited reduced stimulatory effects on IL-1 beta production and inhibitory effects on IL-3-LA secretion by adult PBMC.
Conclusions:
- Preterm neonates have an impaired capacity for cytokine release, potentially affecting immune function.
- Serum factors in preterm infants may modulate immune cell activity, suggesting a feedback mechanism in hematopoiesis.
- Reduced IL-1 beta and IL-3-LA production may underlie the heightened susceptibility to infections observed in preterm newborns.
Abstract:
The capacity of peripheral blood mononuclear cells (PBMC) of preterm neonates to release IL-1 beta and IL-3-like activity (IL-3-LA) has been investigated. In the present study it was found that this capacity is significantly lower than that of their mothers and of control adults. In addition, the results showed that preterm serum has a lower stimulatory effect on IL-1 beta production and an inhibitory effect on IL-3-LA secretion by PBMC of adult controls, in comparison with maternal and adult sera. These findings suggest an additional feedback mechanism for control of haematopoiesis in premature neonates. It is possible that the lower production of IL-1 beta and IL-3-LA may be involved in the increased susceptibility to infections of preterm newborns.